Investing Ideas
/
Canadian Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals

Canadian Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

0 new

High return on equity, past performance and sound balance sheet.

1 companies

BioSyent

Market Cap: CA$112.6m

Acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally.

CA$10.26

2.1%

20.0%